Posted on 4/08/2021
AUGUST 04, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform. Launched at ASCRS in 2019 for ophthalmic surgeons who perform cataract procedures, RayPRO is
Posted on 18/06/2021
JUNE 18, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. The acquisition closed on Friday 18th June 2021. Acquisition Details Rayner has acquired its exclusive Indian distributor, Surgicon, for an undisclosed price. The
Posted on 17/05/2021
New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA
Posted on 10/05/2021
Takeaways: Rayner’s fully preloaded RayOne Aspheric IOL has received NMPA approval for sale in China. RayOne Aspheric will be showcased at the 21st CSCRS from 3-5 June 2021 in Dalian. RayOne Aspheric offers a premium alternative to Rayner’s C-flex/Superflex Aspheric monofocal IOLs. Rayner’s award-winning RayOne IOL platform has been used in over 1.6 million procedures since 2016. Rayner will next
Posted on 6/05/2021
Worthing, UK, 3 May 2021 – With the global rollout of the RayOne EMV™ intraocular lens to markets around the world, Rayner announces today an exciting new campaign intended to extoll the benefits of monovision (including “Mini”, “Micro”, or “Blended”). The Plus1 EMV: A global discussion on Enhanced Monovision™ campaign will shine a light on
Posted on 1/04/2021
Worthing, UK – Rayner, the only British manufacturer of intraocular lenses (IOLs), has been successfully awarded Authorised Economic Operator (AEO) status by HM Revenue & Customs. AEO status is an internationally recognised quality mark indicating that Rayner’s role in the international supply chain is secure and that its customs controls and procedures are efficient and
Posted on 26/03/2021
New York, USA, March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. RayOne EMV was developed in collaboration with world renowned surgeon Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons. “I collaborated with Rayner on bringing to market RayOne EMV, an exciting new product
Posted on 21/01/2021
Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric
Posted on 22/10/2020
Worthing (UK) – Rayner, the manufacturer of the world’s first intraocular lens (IOL) and winner of the 2020 Queen’s Award for Enterprise (Innovation), announced today the launch of their updated web-based Premium IOL Calculator, Raytrace. Developed in line with surgeon feedback, the new Raytrace version 3.5 includes the following improvements: Inclusion of Posterior Corneal Astigmatism
Posted on 21/09/2020
Rayner set to launch RayOne EMV in early October Worthing, UK, September 21st, 2020 – Rayner has announced the upcoming launch of RayOne EMV: a new fully preloaded non-diffractive IOL solution designed specifically to enhance patient outcomes achieved with monovision. Enhanced range of vision Developed in collaboration with Professor Graham Barrett, president of the Australasian